139 related articles for article (PubMed ID: 35396090)
1. The preventive effect of recombinant human hepatocyte growth factor for hepatic steatosis in a rat model of short bowel syndrome.
Yano K; Sugita K; Muto M; Matsukubo M; Onishi S; Kedoin C; Matsui M; Murakami M; Harumatsu T; Yamada K; Yamada W; Kumagai K; Ido A; Kaji T; Ieiri S
J Pediatr Surg; 2022 Jul; 57(7):1286-1292. PubMed ID: 35396090
[TBL] [Abstract][Full Text] [Related]
2. Novel effect of glucagon-like peptide-2 for hepatocellular injury in a parenterally fed rat model of short bowel syndrome.
Yano K; Kaji T; Onishi S; Machigashira S; Nagai T; Harumatsu T; Yamada K; Yamada W; Muto M; Nakame K; Mukai M; Ieiri S
Pediatr Surg Int; 2019 Dec; 35(12):1345-1351. PubMed ID: 31555865
[TBL] [Abstract][Full Text] [Related]
3. The administration of hepatocyte growth factor prevents total parenteral nutrition-induced hepatocellular injury in a rat model.
Matsukubo M; Yano K; Kaji T; Sugita K; Onishi S; Harumatsu T; Nagano A; Matsui M; Murakami M; Yamada K; Yamada W; Muto M; Kumagai K; Ido A; Ieiri S
Pediatr Surg Int; 2021 Mar; 37(3):353-361. PubMed ID: 33388954
[TBL] [Abstract][Full Text] [Related]
4. Superiority of Intestinal Adaptation by Hepatocyte Growth Factor in the Jejunum: An Experimental Study in a Short-Bowel Rat Model.
Sugita K; Yano K; Onishi S; Iwamoto Y; Ogata M; Takada L; Kedoin C; Masakazu M; Harumatsu T; Kawano T; Muto M; Kumagai K; Ido A; Kaji T; Ieiri S
J Pediatr Surg; 2024 Apr; 59(4):627-633. PubMed ID: 38160183
[TBL] [Abstract][Full Text] [Related]
5. The administration of ghrelin improved hepatocellular injury following parenteral feeding in a rat model of short bowel syndrome.
Onishi S; Kaji T; Yamada W; Nakame K; Moriguchi T; Sugita K; Yamada K; Kawano T; Mukai M; Souda M; Yamada S; Yoshioka T; Tanimoto A; Ieiri S
Pediatr Surg Int; 2016 Dec; 32(12):1165-1171. PubMed ID: 27651372
[TBL] [Abstract][Full Text] [Related]
6. Potential mechanisms underlying the effect of hepatocyte growth factor on liver injury in short bowel syndrome model rats.
Sugita K; Yano K; Matsukubo M; Iwamoto Y; Ogata M; Takada L; Kedoin C; Murakami M; Harumatsu T; Onishi S; Kawano T; Muto M; Kumagai K; Ido A; Kaji T; Ieiri S
Pediatr Surg Int; 2023 Nov; 40(1):8. PubMed ID: 37999791
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin stimulates intestinal adaptation following massive small bowel resection in parenterally fed rats.
Onishi S; Kaji T; Yamada W; Nakame K; Machigashira S; Kawano M; Yano K; Harumatsu T; Yamada K; Masuya R; Kawano T; Mukai M; Hamada T; Souda M; Yoshioka T; Tanimoto A; Ieiri S
Peptides; 2018 Aug; 106():59-67. PubMed ID: 29966680
[TBL] [Abstract][Full Text] [Related]
8. The protective effect of fish oil lipid emulsions on intestinal failure-associated liver disease in a rat model of short-bowel syndrome.
Machigashira S; Kaji T; Onishi S; Yamada W; Yano K; Yamada K; Masuya R; Kawano T; Nakame K; Mukai M; Ieiri S
Pediatr Surg Int; 2018 Feb; 34(2):203-209. PubMed ID: 29039050
[TBL] [Abstract][Full Text] [Related]
9. Dose variation of hepatocyte growth factor and its effects on an animal model of TPN-induced liver injury.
Katz MS; Thatch KA; Schwartz MZ
J Surg Res; 2010 Oct; 163(2):294-8. PubMed ID: 20691983
[TBL] [Abstract][Full Text] [Related]
10. Growth factor modulation of hepatic inflammation: a novel approach to the management of total parenteral nutrition-associated liver disease.
Thatch KA; Katz MS; Haber MM; Schwartz MZ
J Pediatr Surg; 2010 Jan; 45(1):89-94. PubMed ID: 20105586
[TBL] [Abstract][Full Text] [Related]
11. The protective effects of hepatocyte growth factor on the intestinal mucosal atrophy induced by total parenteral nutrition in a rat model.
Sugita K; Kaji T; Yano K; Matsukubo M; Nagano A; Matsui M; Murakami M; Harumatsu T; Onishi S; Yamada K; Yamada W; Muto M; Kumagai K; Ido A; Ieiri S
Pediatr Surg Int; 2021 Dec; 37(12):1743-1753. PubMed ID: 34448078
[TBL] [Abstract][Full Text] [Related]
12. Developing a Novel Ambulatory Total Parenteral Nutrition-Dependent Short Bowel Syndrome Animal Model.
Price A; Blomenkamp K; Manithody C; Saxena S; Abraham SM; Greenspon J; Villalona GA; Jain AK
J Surg Res; 2019 Feb; 234():13-19. PubMed ID: 30527464
[TBL] [Abstract][Full Text] [Related]
13. Broad-spectrum antibiotics alter the microbiome, increase intestinal
Maselli KM; Gee K; Isani M; Fode A; Schall KA; Grikscheit TC
Am J Physiol Gastrointest Liver Physiol; 2020 Aug; 319(2):G212-G226. PubMed ID: 32597709
[TBL] [Abstract][Full Text] [Related]
14. The effect of hepatocyte growth factor on intestinal adaption in an experimental model of short bowel syndrome.
Bagias G; Misiakos EP; Charalampopoulos A; Zavras N; Sakellariou S; Schizas D; Sukhotnik I; Giamarelos E; Pikoulis E
Pediatr Surg Int; 2023 Jan; 39(1):80. PubMed ID: 36631569
[TBL] [Abstract][Full Text] [Related]
15. Altered FXR signalling is associated with bile acid dysmetabolism in short bowel syndrome-associated liver disease.
Pereira-Fantini PM; Lapthorne S; Joyce SA; Dellios NL; Wilson G; Fouhy F; Thomas SL; Scurr M; Hill C; Gahan CG; Cotter PD; Fuller PJ; Hardikar W; Bines JE
J Hepatol; 2014 Nov; 61(5):1115-25. PubMed ID: 24999016
[TBL] [Abstract][Full Text] [Related]
16. Decreased liver damage in rat models of short bowel syndrome through DPP4 inhibition.
Sueyoshi R; Furuhashi N; Ishii J; Yamaguchi R; Kawakami M; Tanabe K; Segawa O
Pediatr Surg Int; 2022 Nov; 39(1):21. PubMed ID: 36449115
[TBL] [Abstract][Full Text] [Related]
17. Two-hit rat model of short bowel syndrome and sepsis: independent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver.
Aprahamian CJ; Chen M; Yang Y; Lorenz RG; Harmon CM
J Pediatr Surg; 2007 Jun; 42(6):992-7. PubMed ID: 17560208
[TBL] [Abstract][Full Text] [Related]
18. Effect of alpha-naphthylisothiocyanate-induced liver injury on intestinal adaptation in a rat model of short bowel syndrome.
Sukhotnik I; Razon H; Pollak Y; Hayari L; Bejar J; Mogilner JG; Sylvester KG
Pediatr Surg Int; 2012 Feb; 28(2):161-9. PubMed ID: 21989949
[TBL] [Abstract][Full Text] [Related]
19. Enteral nutrients potentiate glucagon-like peptide-2 action and reduce dependence on parenteral nutrition in a rat model of human intestinal failure.
Brinkman AS; Murali SG; Hitt S; Solverson PM; Holst JJ; Ney DM
Am J Physiol Gastrointest Liver Physiol; 2012 Sep; 303(5):G610-22. PubMed ID: 22744334
[TBL] [Abstract][Full Text] [Related]
20. What is the optimal lipid emulsion for preventing intestinal failure-associated liver disease following parenteral feeding in a rat model of short-bowel syndrome?
Machigashira S; Kaji T; Onishi S; Yano K; Harumatsu T; Yamada K; Yamada W; Matsukubo M; Muto M; Ieiri S
Pediatr Surg Int; 2021 Feb; 37(2):247-256. PubMed ID: 33388967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
